Incannex Healthcare Ltd ADR (IXHL)
$3.80
$0.35
(10.14%)
As on 16-Sep-2026 16:28EDT
Market cap
$39 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
36.38
-
EV/EBITDA
-5.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-4.9
-
Face value
--
-
Shares outstanding
11,964,554
10 Years Aggregate
CFO
$-69.41 Mln
EBITDA
$-83.01 Mln
Net Profit
$-88.84 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Incannex Healthcare Ltd ADR (IXHL)
| -64.6 | 15.9 | 3.5 | -76.1 | -71.8 | -- | -- |
|
BSE Sensex
| -12.2 | -4.7 | -2.5 | -9.1 | 3.1 | 4.8 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Incannex Healthcare Ltd ADR (IXHL)
| -83.1 | -54.0 | -58.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Incannex Healthcare Ltd ADR (IXHL)
|
3.8 | 39.0 | 0.1 | -52.4 | -68,473.2 | -68.8 | -- | 0.5 |
| 18.1 | 5,924.5 | 3,117.6 | 157.4 | 14.7 | -- | 35.4 | 179.4 | |
| 212.0 | 11,563.1 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 132.7 | |
| 68.3 | 14,161.5 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 111.8 | 12,192.4 | 830.8 | 54.9 | 3.2 | 8.1 | 250.6 | 17.3 | |
| 11.7 | 9,754.3 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.6 | 2.4 | |
| 22.9 | 11,421.4 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 275.2 | 5,671.1 | 290.5 | 197.2 | 82.5 | 19.9 | 29.8 | 6.0 | |
| 68.5 | 5,973.8 | 450.9 | 138.6 | 39.1 | 115.6 | 48.7 | 31.1 | |
| 143.1 | 8,434.8 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 18.9 |
Shareholding Pattern
View DetailsAbout Incannex Healthcare Ltd ADR (IXHL)
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose... combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia. Read more
-
MD, CEO & Executive Director
Mr. Joel Bradley Latham
-
MD, CEO & Executive Director
Mr. Joel Bradley Latham
-
Headquarters
Sydney, NSW
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Incannex Healthcare Ltd ADR (IXHL)
What is the current share price of Incannex Healthcare Ltd ADR (IXHL) Today?
The share price of Incannex Healthcare Ltd ADR (IXHL) is $3.80 (NASDAQ) as of 16-Sep-2026 16:28 EDT. Incannex Healthcare Ltd ADR (IXHL) has given a return of -71.75% in the last 3 years.
What is the current PB & PE ratio of Incannex Healthcare Ltd ADR (IXHL)?
Since, TTM earnings of Incannex Healthcare Ltd ADR (IXHL) is negative, P/E ratio is not available.
The P/B ratio of Incannex Healthcare Ltd ADR (IXHL) is 0.52 times as on 11-Sep-2026, a 93 discount to its peers’ median range of 7.57 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.05 |
0.17 |
2024 |
-0.90 |
1.49 |
2023 |
-0.10 |
0.23 |
2022 |
-3.08 |
1.28 |
2021 |
-- |
-- |
What is the 52 Week High and Low of Incannex Healthcare Ltd ADR (IXHL)?
The 52-week high and low of Incannex Healthcare Ltd ADR (IXHL) are Rs 155.43 and Rs 2.49 as of 17-Sep-2026.
What is the market cap of Incannex Healthcare Ltd ADR (IXHL)?
Incannex Healthcare Ltd ADR (IXHL) has a market capitalisation of $ 39 Mln as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Incannex Healthcare Ltd ADR (IXHL)?
Before investing in Incannex Healthcare Ltd ADR (IXHL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.